Case Study Of The Sun Pharmaceutical Industry

1070 Words5 Pages
Introduction
Pharmaceutical industry, the discovery, development, and manufacture of drugs and medications (pharmaceuticals) by public organizations and private organizations .Pharmaceutical companies may deal in generic or brand medications and medical devices . The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable. In 2014, total pharmaceutical revenues worldwide had exceeded one trillion U.S. dollars for the first time. North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry . Sun Pharmaceuticals Industries Limited plans to acquire 85.1 per cent stake in Russian company Biosintez for US$ 24 million for increasing its presence in Russia through local manufacturing capability.
Sun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983 in Vapi with five products to treat psychiatry ailments. Cardiology products were introduced in 1987 followed by gastroenterology products in 1989. Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopaedics, ophthalmology, gastroenterology and nephrology. The 2014 acquisition of Ranbaxy has made the company the largest pharma company in
…show more content…
It has around 19 manufacturing plants in almost 6 continents. Recently it has set up manufacturing facilities in Mexico, Bangladesh and Brazil. Sun Pharmaceutical has been spending a lot in its R&D projects and thus leading to various successful endeavours. Sun Pharma has its headquarters in Mumbai, Maharashtra. The plants are located in India, Canada, Egypt, Hungary, Mexico, Us, Brazil, Romania, Ireland, Morocco, Nigeria, South Africa etc. Sun Pharma has been successfully serving patients in around 150 nations across the
Get Access